David C.W. Lau
Editor in Chief, Canadian Journal of Diabetes | Diabetes Canada
Calgary, AB, CANADA
Dr. Lau has chaired the 1998, 2003 and 2008 Diabetes Canada's Clinical Practice Guidelines for the management of Diabetes.
Biography
Dr. David Lau is Professor of Medicine, Biochemistry and Molecular Biology at the University of Calgary Cumming School of Medicine. He is currently the Editor-in-Chief of the Canadian Journal of Diabetes, and President, Canadian Association of Bariatric Physicians and Surgeons, and President of Obesity Canada.
Dr. Lau is a practising endocrinologist who specializes in obesity diabetes, and lipid disorders. His research interests include fat cell biology in health and obesity, development of insulin resistance in obesity and diabetes, and cellular mechanisms of diabetic vascular complications. He is also involved in population health and clinical research programmes in diabetes, obesity and lipid disorders.
Dr. Lau has published over 150 scientific papers in peer-reviewed medical journals, periodicals and books. He was Chair of the evidence-based Obesity Canada Clinical Practice Guidelines (CPG) Steering Committee and Expert Panel, and lead author of the 2007 CPG publication in the Canadian Medical Association Journal. Dr. Lau was an Expert Panel member of the 2013 evidence-based Diabetes Canada Clinical Practice Guidelines (he also served as an expert member for the 1998, 2003, 2008 updates), and a member of the primary panel expert committee on the 2012 Canadian Cardiovascular Society Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult as well as the expert panel of the 2009 Canadian Cardiovascular Society lipid guidelines.
Dr. Lau was honored as the top 20 notable Calgarians, and top 50 Albertans in 2004 for his exemplary contributions to improve the health of Albertans.
Industry Expertise (6)
Program Development
Public Policy
Research
Health and Wellness
Training and Development
Education/Learning
Areas of Expertise (8)
Metabolism
Obesity
Lipid Disorders
Population Health
Clinical Research
Vascular Complications
Diabetes
Endocrinology
Accomplishments (1)
Physician Scientist Lecture Award (professional)
2008-01-01
Awarded by the Canadian Lipoprotein Conference.
Education (3)
Royal College of Physicians Canada: Fellow, Endocrinology
University of Toronto: Ph.D., Internal Medicine and Endocrinology
University of Toronto: B.Sc., Biology
Affiliations (3)
- Obesity Canada : Founding President
- University of Calgary : Chair, Diabetes and Endocrine Research Group
- University of Calgary : Adjunct Professor, Faculty of Kinesology
Links (1)
Media Appearances (1)
Fighting far with fat: Muscle stem cells may hold key to battling obesity
CTV News online
2013-02-05
“This is fundamental science and is a long way from having clinical application,” Dr. David C.W. Lau, editor of the Canadian Journal of Diabetes and the president of Obesity Canada, told CTV in an email statement. “However, the science is quite exciting and novel, telling us that we could potentially turn on brown fat to burn energy instead.”...
Articles (5)
The obesity epidemic and its impact on hypertension
Canadian Journal of Cardiology
2012-01-01
Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 ...
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]
Canadian Medical Association Journal
2007-01-01
Obesity is now reaching epidemic proportions in both developed and developing countries and is affecting not only adults but also children and adolescents. Over the last 20 years, obesity has become the most prevalent nutritional problem in the world, eclipsing ...
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
British Medical Journal
2007-01-01
To summarise the long term efficacy of anti- obesity drugs in reducing weight and improving health status. Design Updated meta-analysis of randomised trials. Data sources Medline, Embase, the Cochrane controlled trials register, the Current Science ...
Adipokines: molecular links between obesity and atheroslcerosis
American Journal of Physiology-Heart and Circulatory Physiology
2005-01-01
Atherosclerotic disease remains the leading cause of death in industrialized nations despite major advances in its diagnosis, treatment, and prevention. The increasing epidemic of obesity, insulin resistance, and diabetes will likely add to this burden. Increasingly, it is ...
Exaggerated replication in culture of adipocyte precursors from massively obese persons
Metabolism
1981-01-01
The characteristics of omental adipocyte precursors from massively obese patients, whose average body weights were 231%(range 170–369) of reference values, were studied in propagating culture. When compared to cells from lean subjects, the adipocyte ...
Social